ZJYLNasdaq

JIN MEDICAL INTERNATIONAL LTD.

Healthcare·Oncology·Changzhou, China
OncologyNeurologyCardiovascular

JIN MEDICAL INTERNATIONAL LTD. (ZJYL): 10 pipeline candidates · 3 clinical trials. Updated within the last hour.

9.4/10

BioSniper Score

2-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health8.8

D/E 0.80 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

10 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for JIN MEDICAL INTERNATIONAL LTD.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$18.9M

Cash

$7.5M

Quarterly Burn

—

Runway

—

Revenue

—

Pipeline (10 candidates)

DrugPhase
jin chang sunglasses—
jin chang sunglasses—
powder free vinyl patient examination gloves—
powder free vinyl patient examination gloves—
powered wheelchair dyw30a—
powered wheelchair dyw30a—
scooter—
scooter—
surgical mask—
surgical mask—
3 clinical trials·CEO: Mr. Erqi Wang

Frequently asked questions

How many drug candidates are in JIN MEDICAL INTERNATIONAL LTD.'s pipeline?

JIN MEDICAL INTERNATIONAL LTD. (ZJYL) has 10 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is JIN MEDICAL INTERNATIONAL LTD.'s market capitalization?

JIN MEDICAL INTERNATIONAL LTD.'s market capitalization is approximately $18.9M.

Who is the CEO of JIN MEDICAL INTERNATIONAL LTD.?

Mr. Erqi Wang is the chief executive officer of JIN MEDICAL INTERNATIONAL LTD. (ZJYL).

Get the full picture on JIN MEDICAL INTERNATIONAL LTD.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar